REGISTERED
on 04 Aug 2020
Last Applicant/ Owned by
7F, 570 Samseong-ro, Gangnam-gu
Seoul
KR
06163
Serial Number
88174398 filed on 30th Oct 2018
Registration Number
6115846 registered on 04th Aug 2020
Correspondent Address
Daniel R. Mello
Daniel R. Mello Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Washington, DC 20001
United States
Filing Basis
No Filing Basis
Disclaimer
NO DATA
MEZZION
Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely single ventricle heart disease (S Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Medical testing and screening services, namely, medical diagnostic testing services and medical screening the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Medical and pharmaceutical research for the treatment of cardiac disease and disorders, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation and development services; scientific and technological research services related thereto, namely, scientific research services for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation ; medical testing services, namely, providing medical testing services and information in the field of the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; conducting clinical trials for others
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of diseases and disorders, Pharmaceutical preparations for the treatment of cardiac diseases and disorders; Pharmaceutical preparations for the treatment of cardiac diseases and disorders, namely, single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation; medicinal preparations for cardiac disease, namely single ventricle heart disease (SVHD); pharmaceuticals, namely, drugs for the treatment of cardiac disease, namely single ventricle heart disease (SVHD), including SVHD subjects who have undergone Fontan Palliation
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 88174398
Mark Type
No Service Mark
Attorney Docket Number
No 16451.0012
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 23rd Aug 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 23rd Aug 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 23rd Aug 2024 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
| 23rd Aug 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 23rd Aug 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 29th May 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 29th May 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| 29th May 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 29th May 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 29th May 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |